债券代码：113634 债券简称：珀莱转债 证券代码：603605 证券简称：珀莱雅 公告编号：2025-027 珀莱雅化妆品股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利1.19元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/16 | － | 2025/6/17 | 2025/6/17 | 差异化分红送转： 是 一、通过分配方案的股东大会届次和日期 本次利润分配方案经珀莱雅化妆品股份有限公司（以下简称"公司"） 2025 年 5 月 19 日的 2024年年度股东大会审议通过。 二、分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东 ...

| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-025 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司关于 调整 2024 年度利润分配现金分红总额的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 珀莱雅化妆品股份有限公司（以下简称"公司"）分别于 2025 年 4 月 23 日、2025 年 5 月 19 日召开第四届董事会第三次会议、第四届监事会第三次会议 及 2024 年年度股东大会，审议通过了《公司 2024 年度利润分配方案》。本次利 润分配方案如下：以实施权益分派股权登记日的总股本（扣除公司回购专用证券 账户中的股份）为基数，向在册全体股东每 10 股派发 11.90 元现金红利（含税）。 以 2024 年 12 月 31 日的总股本 396,247,555 股为测算基数，扣除公司回购专用 证券账户中的股份 2,210,825 股，预计合计派发现金红利 468,903,708.70 元（含 税），占合并 ...

Core Viewpoint - The legal opinion letter from Grandall Law Firm (Hangzhou) confirms that Proya Cosmetics Co., Ltd.'s differentiated dividend distribution for the year 2024 complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][9]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's share repurchase plan, which was disclosed on December 20, 2023, involving a total repurchase amount between RMB 100 million and RMB 200 million, with a maximum repurchase price of RMB 130 per share [5][6]. - The company repurchased a total of 2,210,825 shares, which will not participate in profit distribution, leading to the implementation of differentiated dividends for the remaining shares [6][8]. - The 2024 profit distribution plan proposes a cash dividend of RMB 11.90 per 10 shares for all registered shareholders, excluding shares held in the repurchase account [6][7]. Group 2: Legal Compliance and Verification - The law firm conducted thorough verification of the facts related to the differentiated dividend distribution, ensuring the legality and compliance of the proposed actions under the Company Law and Securities Law [2][5]. - The law firm confirms that all documents and statements provided by Proya are complete and truthful, with no omissions that could affect the legal opinion [2][3]. - The legal opinion letter is intended solely for the purpose of the differentiated dividend distribution and cannot be used for other purposes without prior written consent from the law firm [3].

Core Viewpoint - The company has announced an adjustment to its 2024 profit distribution cash dividend total, reflecting changes in its total share capital due to the conversion of convertible bonds [2][4]. Summary by Sections Profit Distribution Plan - The company approved the 2024 profit distribution plan, which includes a cash dividend of 11.90 yuan (including tax) for every 10 shares held, based on the total share capital as of December 31, 2024 [2]. - The total number of shares for calculation is 396,247,555, excluding 2,210,825 shares held in the company's repurchase account, leading to an estimated total cash dividend distribution of 468,903,708.70 yuan, which represents 30.21% of the net profit attributable to shareholders [2]. Changes in Share Capital - The total share capital has changed due to the conversion of the company's convertible bonds, which began on June 14, 2022. As of the equity registration date of June 9, 2025, the total share capital increased to 396,247,626 shares [3]. - The company plans to maintain the per-share distribution ratio unchanged, adjusting the total distribution amount accordingly if there are changes in total share capital before the equity registration date [2][4]. Announcement and Compliance - The company has ensured that the announcement regarding the profit distribution does not contain any false records, misleading statements, or significant omissions, and it assumes legal responsibility for the accuracy and completeness of the content [1].

Core Points - The company announced a cash dividend of 1.19 CNY per share (including tax) for its A shares [1][4] - The total cash dividend distribution amounts to approximately 468.90 million CNY (including tax) based on a total share capital of 394,036,801 shares [2][4] - The ex-dividend date is set for June 17, 2025, with the record date being June 16, 2025 [1][2] Dividend Distribution Plan - The dividend distribution plan was approved at the company's annual general meeting on May 19, 2025 [1] - The cash dividend will be distributed to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [1][2] - The company will not distribute dividends to shares held in the repurchase special securities account [2][3] Tax Implications - For individual shareholders holding shares for over one year, the dividend income is temporarily exempt from personal income tax, resulting in an actual cash dividend of 1.19 CNY per share [3][4] - For shares held for one year or less, the company will not withhold personal income tax at the time of distribution, but tax will be calculated and deducted upon the transfer of shares [4][5] - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net cash dividend of 1.071 CNY per share [5] Adjustments to Convertible Bonds - Following the dividend distribution, the conversion price of the company's convertible bonds (referred to as "Perlai Convertible Bonds") will be adjusted from 97.41 CNY per share to 96.23 CNY per share, effective June 17, 2025 [6]

| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-026 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司 关于 2024 年度权益分派调整可转债转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券停复牌情况：适用 因实施 2024 年度权益分派, 珀莱雅化妆品股份有限公司（以下简称"公司"）的 相关证券停复牌情况如下： | 证券代码 | 证券简称 | 停复牌类型 | 停牌起始日 | 停牌 期间 | 停牌终止日 | 复牌日 | | --- | --- | --- | --- | --- | --- | --- | | 113634 | 珀莱转债 | 可转债转股 | | | 2025/6/16 | 2025/6/17 | | | | 停牌 | | | | | 经中国证券监督管理委员会《关于核准珀莱雅化妆品股份有限公司公开发行 可转换公司债券的批复》（证监许可[2021]3408 号）核准，并经上 ...

珀莱雅化妆品股份有限公司 差异化分红事项 之 专项法律意见书 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼邮编：310008 国浩律师（杭州）事务所 关于 差异化分红事项 之 GrandallBuilding,No.2＆No.15,BlockB,BaitaPark,OldFuxingRoad,Hangzhou,Zhejiang310008,China 电话/Tel:(+86)(571)85775888 传真/Fax:(+86)(571)85775643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年五月 国浩律师（杭州）事务所 珀莱雅差异化分红专项法律意见书 国浩律师（杭州）事务所 关于 珀莱雅化妆品股份有限公司 专项法律意见书 致：珀莱雅化妆品股份有限公司 国浩律师（杭州）事务所接受珀莱雅化妆品股份有限公司（以下简称"珀莱 雅"或"公司"）的委托，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公 司股 ...

| 证券代码：603605 | 证券简称：珀莱雅 | 公告编号：2025-025 | | --- | --- | --- | | 债券代码：113634 | 债券简称：珀莱转债 | | 珀莱雅化妆品股份有限公司关于 调整 2024 年度利润分配现金分红总额的公告 见公司于 2025 年 6 月 5 日在上海证券交易所网站（www.sse.com.cn）及指定媒 体披露的《实施 2024 年度权益分派时"珀莱转债"停止转股的提示性公告》（公 告编号：2025-023）。 根据上述公司总股本变动情况，公司按照每股分配比例不变的原则，对2024 年度利润分配现金分红总额进行相应调整，变动情况如下： 以实施权益分派股权登记日的总股本（扣除公司回购专用证券账户中的股份） 为基数，向在册全体股东每 10 股派发 11.90 元现金红利（含税）。截至 2025 年 6 月 9 日，公司总股本为 396,247,626 股，扣除公司回购专用证券账户中的股份 2,210,825 股后的股本为 394,036,801 股，以此为基数计算合计拟派发现金红利 468,903,793.19 元（含税）。本次变动后，2024 年度公司现 ...

债券代码：113634 债券简称：珀莱转债 证券代码：603605 证券简称：珀莱雅 公告编号：2025-027 珀莱雅化妆品股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 每股分配比例 A 股每股现金红利1.19元（含税） | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/16 | － | 2025/6/17 | 2025/6/17 | 差异化分红送转： 是 一、通过分配方案的股东大会届次和日期 本次利润分配方案经珀莱雅化妆品股份有限公司（以下简称"公司"） 2025 年 5 月 19 日的 2024年年度股东大会审议通过。 二、分配方案 1. 发放年度：2024年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《 ...

Group 1 - The beauty and personal care sector has shown strong performance in Q1 2025, with the SW Beauty Care Index rising by 13.4%, leading all 31 SW primary industries [4][10][12] - The cosmetics segment is focusing on enhancing brand matrices and introducing new ingredients, benefiting from an optimized competitive landscape [4][6] - The medical beauty market is evolving with new products stimulating consumer interest, and domestic companies are expected to become major competitors in the light medical beauty sector [4][6] Group 2 - The e-commerce sector is witnessing new consumption models and brands, which are helping to drive growth in the industry [4][6] - The report recommends several companies in the cosmetics sector, including Up Beauty and Proya, which have low PE multiples and strong growth potential [4][6] - In the medical beauty segment, companies with high R&D barriers and strong profitability, such as Aimeike, are highlighted as key investment opportunities [4][6] Group 3 - The personal care market is projected to reach CNY 283.3 billion by 2024, with a compound annual growth rate (CAGR) of 8.4% from 2023 to 2028 [32][34] - Domestic brands are increasingly replacing foreign brands in the personal care sector, with a notable rise in innovative products and marketing strategies [32][36] - The high-end market is experiencing significant growth, with premium products seeing a 27% increase in average transaction value in H2 2024 [44]